Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
Go back to Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib| (NASDAQ: APLM) | Delayed: 24.95 +0.83 (3.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.12 | 52 Week High | $ | |||
| Open | $24.95 | 52 Week Low | $ | |||
| Day High | $24.95 | P/E | N/A | |||
| Day Low | $24.95 | EPS | $ | |||
| Volume | 1,321 | |||||
| (NASDAQ: APLMW) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $ | |||
| Open | $0.01 | 52 Week Low | $ | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $ | |||
| Volume | 1,215 | |||||
